MRPS17 and gastric cancer: Furthermore, a more recent human study has revealed that MRPS17 promotes gastric cancer metastasis through abnormal signaling of phosphatidylinositol-3 kinase/Akt (PI3K/Akt) [64], a pathway commonly dysregulated in NSCLC [65].